Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Public ClinicalTrials.gov record NCT03409107. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 28-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center, Study in Recombinant Human Erythropoietin (rhEPO) naïve Non-dialysis Participants With Anemia Associated With Chronic Kidney Disease to Evaluate the Efficacy, Safety and Effects on Quality of Life of Daprodustat Compared to Placebo
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this multi-center study in non-dialysis participants with anemia associated with CKD is to evaluate safety, efficacy and quality of life of daprodustat compared to placebo.
Study identification
- NCT ID
- NCT03409107
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 614 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 5, 2018 (Actual)
- Primary completion
- Oct 7, 2020 (Actual)
- Completion
- Oct 7, 2020 (Actual)
- Last update posted
- Apr 2, 2024
2018 – 2020
United States locations
- U.S. sites
- 49
- U.S. states
- 20
- U.S. cities
- 47
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| GSK Investigational Site | Homewood | Alabama | 35209 | — |
| GSK Investigational Site | Little Rock | Arkansas | 72204 | — |
| GSK Investigational Site | Downey | California | 90242 | — |
| GSK Investigational Site | Fresno | California | 93720 | — |
| GSK Investigational Site | Lynwood | California | 90262 | — |
| GSK Investigational Site | Northridge | California | 91324 | — |
| GSK Investigational Site | Northridge | California | 91325 | — |
| GSK Investigational Site | Riverside | California | 82503 | — |
| GSK Investigational Site | Salinas | California | 93901 | — |
| GSK Investigational Site | Santa Ana | California | 92704 | — |
| GSK Investigational Site | Denver | Colorado | 80230 | — |
| GSK Investigational Site | Hartford | Connecticut | 06112 | — |
| GSK Investigational Site | Middlebury | Connecticut | 06762 | — |
| GSK Investigational Site | Coral Springs | Florida | 33067 | — |
| GSK Investigational Site | Hollywood | Florida | 33024 | — |
| GSK Investigational Site | Kissimmee | Florida | 34741 | — |
| GSK Investigational Site | Lauderdale Lakes | Florida | 33313 | — |
| GSK Investigational Site | Pembroke Pines | Florida | 33028 | — |
| GSK Investigational Site | Tampa | Florida | 33614 | — |
| GSK Investigational Site | Adairsville | Georgia | 30103 | — |
| GSK Investigational Site | Macon | Georgia | 31201 | — |
| GSK Investigational Site | Macon | Georgia | 31217 | — |
| GSK Investigational Site | Statesboro | Georgia | 30458 | — |
| GSK Investigational Site | Indianapolis | Indiana | 46260 | — |
| GSK Investigational Site | Overland Park | Kansas | 66210 | — |
| GSK Investigational Site | Buckley | Michigan | 49620 | — |
| GSK Investigational Site | Detroit | Michigan | 48202 | — |
| GSK Investigational Site | Saint Clair Shores | Michigan | 48081 | — |
| GSK Investigational Site | Brookhaven | Mississippi | 39601 | — |
| GSK Investigational Site | St Louis | Missouri | 63136 | — |
| GSK Investigational Site | Rochester | New Hampshire | 03867 | — |
| GSK Investigational Site | Asheville | North Carolina | 28801 | — |
| GSK Investigational Site | Charlotte | North Carolina | 28262 | — |
| GSK Investigational Site | Durham | North Carolina | 27704 | — |
| GSK Investigational Site | Midwest City | Oklahoma | 73130 | — |
| GSK Investigational Site | Oklahoma City | Oklahoma | 73112 | — |
| GSK Investigational Site | Beaver | Pennsylvania | 15009 | — |
| GSK Investigational Site | Duncansville | Pennsylvania | 16635 | — |
| GSK Investigational Site | Scottdale | Pennsylvania | 15683 | — |
| GSK Investigational Site | Smithfield | Pennsylvania | 15478 | — |
| GSK Investigational Site | West Reading | Pennsylvania | 19611 | — |
| GSK Investigational Site | Orangeburg | South Carolina | 29118 | — |
| GSK Investigational Site | Kingsport | Tennessee | 37660 | — |
| GSK Investigational Site | Memphis | Tennessee | 38163 | — |
| GSK Investigational Site | DeSoto | Texas | 75115 | — |
| GSK Investigational Site | El Paso | Texas | 79935 | — |
| GSK Investigational Site | McAllen | Texas | 78503 | — |
| GSK Investigational Site | Waxahachie | Texas | 75165 | — |
| GSK Investigational Site | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 119 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03409107, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 2, 2024 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03409107 live on ClinicalTrials.gov.